Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
Clinical trial NCT03514368 · RECRUITING
Trial details
- NCT number
- NCT03514368
- Sponsor
- Institut Claudius Regaud
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2029-11-01
- Enrollment
- 770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.